Gad AAM, et al. - In this prospective, interventional, randomized clinical study at Alpha Vision Center, Zagazig, Egypt, authors investigated the effectiveness of the biodegradable collagen implant Ologen as an adjuvant in phaco-viscocanalostomy in subjects with coexisting cataract and primary open angle glaucoma. They noticed a significant decline in intraocular pressure (IOP) in the OloPhacovisco group and complete success happened in 23 eyes in the Phacovisco group and in 32 eyes in the OloPhacovisco group. They concluded a tremendous success rate concerning complete success in individuals receiving Ologen implant with no significant operative or postoperative complexities.